Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in AEMD held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 24K | $53K | β | 3.200% | 0.00% |
| 2 | Ikarian Capital, LLC | 14K | $31K | 0.0% | 1.887% | 0.00% |
| 3 | Shay Capital LLC | 14K | $31K | β | 1.855% | 0.00% |
| 4 | XTX Topco Ltd | 13K | $29K | β | 1.753% | 0.00% |
| 5 | MORGAN STANLEY | 2K | $4K | 0.0% | 0.269% | 0.00% |
| 6 | Tower Research Capital LLC (TRC) | 2K | $4K | β | 0.212% | 0.00% |
| 7 | UBS Group AG | 895 | $2K | β | 0.118% | 0.00% |
| 8 | GROUP ONE TRADING, L.P. | 14 | $31 | 0.0% | 0.002% | 0.00% |
| 9 | BlackRock, Inc. | 10 | $22 | 0.0% | 0.001% | 0.00% |
| 10 | Caitong International Asset Management Co., Ltd | 8 | $18 | β | 0.001% | 0.00% |
| 11 | WELLS FARGO & COMPANY/MN | 3 | $6 | 0.0% | 0.000% | 0.00% |
| 12 | DANSKE BANK A/S | 1 | $2 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in AEMD β a direct measure of their conviction.
Filings activity in AEMD during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new AEMD position in Q1 2026
Institutions that fully closed their AEMD position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 12 | +50% | 10.08% | +7.11 pp | $0M | +240% |
| Q4 2025 | 8 | 60% | 2.97% | 16.04 pp | $0M | 84% |
| Q3 2025 | 20 | +25% | 19.01% | 12.29 pp | $0M | 39% |
| Q2 2025 | 16 | 36% | 31.30% | 46.56 pp | $0M | 60% |
| Q1 2025 | 25 | +4.2% | 77.86% | 6.75 pp | $1M | 8.0% |
| Q4 2024 | 24 | +26% | 84.61% | +72.47 pp | $1M | +597% |
| Q3 2024 | 19 | 5.0% | 12.14% | +1.72 pp | $0M | +17% |
| Q2 2024 | 20 | β | 10.42% | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying AEMD stock.
Based on Q1 2026 13F filings, institutional ownership of Aethlon Medical, Inc. stands at 10.1%, held across 12 reporting institutions.
GEODE CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of AEMD, with approximately 24,364 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of AEMD.
Our composite Smart Money Score for AEMD is 55 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
6 institutions opened new positions in AEMD during Q1 2026, while 2 fully exited. 0 added to existing positions and 6 trimmed.
AEMD institutional ownership rose by 7.11 percentage points quarter-over-quarter, with a net change of +4 holders.
The top 10 institutions account for 100.0% of all reported 13F value in AEMD, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Aethlon Medical, Inc. (AEMD) Institutional Ownership